Quark Biotech, Inc. Files with SEC for $86.3 Million IPO
3/30/2007 10:11:36 AM
More...
|
The Day In Review: Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Pays $515 Million For AnorMED (AOM.TO)
9/26/2006 6:08:10 PM
More...
|
Pfizer Inc. (PFE) Expands Research Commitment To Ophthalmology Through Licensing Agreement With Quark Biotech, Inc.; Atugen AG Will Receive Payments Up To US$95 Million
9/26/2006 12:06:22 PM
More...
|
Alnylam Pharmaceuticals (ALNY) Grants Quark Biotech, Inc. A License To Develop And Commercialize Two RNAi Therapeutic Products
9/26/2006 11:47:58 AM
More...
|
Quark Biotech, Inc. Awarded Certification For Agilent Technologies Inc.'s (A) Certified Microarray Service Provider Program
10/19/2005 5:13:02 PM
More...
|
Quark Biotech, Inc. Discovers Role Of RTP801 In The Development Of Age-related Macular Degeneration
10/19/2005 5:12:59 PM
More...
|
Quark Biotech, Inc. Receives Notice Of Allowance For U.S. Patent On p53 Inhibitor
10/19/2005 5:12:54 PM
More...
|
Quark Biotech, Inc. Discovers Role Of Ero-1L Alpha Gene In Cancer: Involvement In Protein Secretion Under Hypoxic Conditions
10/19/2005 5:12:51 PM
More...
|
Sanwa Kagaku Kenkyusho And Quark Biotech, Inc. Enter Collaboration To License Dyslipidemia Therapy
10/19/2005 5:12:39 PM
More...
|
Quark Biotech, Inc. Announces Discovery Of Novel Target For Treatment Of Ischemia-induced Retinopathy
10/19/2005 5:12:18 PM
More...
|
|